Cargando…

High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies

Defining long-term protective immunity to SARS-CoV-2 is one of the most pressing questions of our time and will require a detailed understanding of potential ways this virus can evolve to escape immune protection. Immune protection will most likely be mediated by antibodies that bind to the viral en...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrett, Meghan E., Galloway, Jared, Chu, Helen Y., Itell, Hannah L., Stoddard, Caitlin I., Wolf, Caitlin R., Logue, Jennifer K., McDonald, Dylan, Weight, Haidyn, Matsen, Frederick A., Overbaugh, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096189/
https://www.ncbi.nlm.nih.gov/pubmed/34010620
http://dx.doi.org/10.1016/j.cell.2021.04.045
_version_ 1783688113161240576
author Garrett, Meghan E.
Galloway, Jared
Chu, Helen Y.
Itell, Hannah L.
Stoddard, Caitlin I.
Wolf, Caitlin R.
Logue, Jennifer K.
McDonald, Dylan
Weight, Haidyn
Matsen, Frederick A.
Overbaugh, Julie
author_facet Garrett, Meghan E.
Galloway, Jared
Chu, Helen Y.
Itell, Hannah L.
Stoddard, Caitlin I.
Wolf, Caitlin R.
Logue, Jennifer K.
McDonald, Dylan
Weight, Haidyn
Matsen, Frederick A.
Overbaugh, Julie
author_sort Garrett, Meghan E.
collection PubMed
description Defining long-term protective immunity to SARS-CoV-2 is one of the most pressing questions of our time and will require a detailed understanding of potential ways this virus can evolve to escape immune protection. Immune protection will most likely be mediated by antibodies that bind to the viral entry protein, spike (S). Here, we used Phage-DMS, an approach that comprehensively interrogates the effect of all possible mutations on binding to a protein of interest, to define the profile of antibody escape to the SARS-CoV-2 S protein using coronavirus disease 2019 (COVID-19) convalescent plasma. Antibody binding was common in two regions, the fusion peptide and the linker region upstream of the heptad repeat region 2. However, escape mutations were variable within these immunodominant regions. There was also individual variation in less commonly targeted epitopes. This study provides a granular view of potential antibody escape pathways and suggests there will be individual variation in antibody-mediated virus evolution.
format Online
Article
Text
id pubmed-8096189
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80961892021-05-05 High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies Garrett, Meghan E. Galloway, Jared Chu, Helen Y. Itell, Hannah L. Stoddard, Caitlin I. Wolf, Caitlin R. Logue, Jennifer K. McDonald, Dylan Weight, Haidyn Matsen, Frederick A. Overbaugh, Julie Cell Article Defining long-term protective immunity to SARS-CoV-2 is one of the most pressing questions of our time and will require a detailed understanding of potential ways this virus can evolve to escape immune protection. Immune protection will most likely be mediated by antibodies that bind to the viral entry protein, spike (S). Here, we used Phage-DMS, an approach that comprehensively interrogates the effect of all possible mutations on binding to a protein of interest, to define the profile of antibody escape to the SARS-CoV-2 S protein using coronavirus disease 2019 (COVID-19) convalescent plasma. Antibody binding was common in two regions, the fusion peptide and the linker region upstream of the heptad repeat region 2. However, escape mutations were variable within these immunodominant regions. There was also individual variation in less commonly targeted epitopes. This study provides a granular view of potential antibody escape pathways and suggests there will be individual variation in antibody-mediated virus evolution. Elsevier Inc. 2021-05-27 2021-05-04 /pmc/articles/PMC8096189/ /pubmed/34010620 http://dx.doi.org/10.1016/j.cell.2021.04.045 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Garrett, Meghan E.
Galloway, Jared
Chu, Helen Y.
Itell, Hannah L.
Stoddard, Caitlin I.
Wolf, Caitlin R.
Logue, Jennifer K.
McDonald, Dylan
Weight, Haidyn
Matsen, Frederick A.
Overbaugh, Julie
High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
title High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
title_full High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
title_fullStr High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
title_full_unstemmed High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
title_short High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
title_sort high-resolution profiling of pathways of escape for sars-cov-2 spike-binding antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096189/
https://www.ncbi.nlm.nih.gov/pubmed/34010620
http://dx.doi.org/10.1016/j.cell.2021.04.045
work_keys_str_mv AT garrettmeghane highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT gallowayjared highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT chuheleny highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT itellhannahl highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT stoddardcaitlini highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT wolfcaitlinr highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT loguejenniferk highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT mcdonalddylan highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT weighthaidyn highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT matsenfredericka highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies
AT overbaughjulie highresolutionprofilingofpathwaysofescapeforsarscov2spikebindingantibodies